Trial site
Osrodek Badawczo Naukowo Dydaktyczny Chorob Otepiennych Im. Ksiedza Henryka Kardynala Gulbinowicza Osrodek Alzheimerowski Sp. z o.o.
- 5running trials
- 5closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease10 trials
- Mild cognitive impairment3 trials
- Phase
- Phase 38 trials
- Phase 22 trials
- Status
- Completed5 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche2 trials
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
- Novo Nordisk A/S2 trials
- AriBio Co., Ltd.1 trial
- Eli Lilly and Company1 trial
- and 2 more
Running trials
Recruiting
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease3 recruiting
Closed trials
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026